You searched for "outcomes"

1634 results found

Changing the post cataract surgery review pathway – is patient safety compromised?

Cataract surgery continues to be the most commonly performed elective surgical procedure in the UK, with an annual rate of approximately 4150/100,000 people over the age of 65 accounting for a significant proportion of the surgical workload of most ophthalmologists...

Optical sector bodies urge GOC to rethink approach to CPD reform

The UK’s main optical sector bodies have responded to the General Optical Council’s (GOC) consultation on proposed reforms to continuing professional development (CPD), warning that the current proposals could have implications for public protection if not carefully implemented and may...

OpenEyes – Community edition

Moving to an electronic patient record (EPR) is all the rage these days, even in the District General Hospitals (DGHs). When I am not writing these articles I work in one such hospital. At Bolton Foundation Trust we deployed OpenEyes...

Reducing myopia progression

This paper reports a literature review to discuss the environmental considerations and treatment options that can prevent the progression of myopia, including time spent outdoors, reduction of near vision activities, spectacle types, contact lens type and pharmacological treatment. The review...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...

Researchers pursue personalised pathways for glaucoma care

Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.

Orbis and Heidelberg Engineering announce expansion of collaboration during a special visit to the Flying Eye Hospital in Rwanda

The medtech imaging and data solutions company, Heidelberg Engineering, and sightsaving nonprofit, Orbis, have come together on board the Orbis Flying Eye Hospital during its latest programme in Kigali, Rwanda, to announce the expansion of their collaboration in making educational...

Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders

This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...

Results of vitrectomy in epiretinal membranes secondary to retinal vein occlusions

This retrospective, observational multicentre study investigated the anatomic and functional results of vitrectomy associated with the peeling of secondary epiretinal membranes (ERM) in patients with retinal vein occlusion (RVO) and determined the prognostic factors of surgical outcomes. Data was collected...

PlusoptiX and SPOT screening

The goal of this study was to determine whether an instrument that uses referral criteria having a high specificity (plusoptiX S08) would fail to refer children who have significant amblyopia and who would have been detected by an instrument using...

PROM rating scales

The authors evaluated three commonly used Likert-type rating scales with an aim to determine which scale performed best when administering questions to children with eye disorders, and their parents. Three scales looked at frequency, severity and difficulty. An initial questionnaire...

Topical atorvastatin for dry eye and blepharitis

Dry eye is a very common problem with 20% of the population affected and is frequently associated with blepharitis (DEB), which has an over prevalence of about 40%. The aim of this study was to evaluate a topical atorvastatin formulation...